HealthTech Arkansas and MedAxiom have come together to create a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market. Together, HealthTech Arkansas and MedAxiom use their respective expertise to bring the latest cardiovascular healthcare innovations to the patients who need them most.

Powered By:

 

HealthTech Arkansas helps to drive innovation within the state’s ten largest hospitals and health systems through accelerators and internal innovation programming. Its accelerator is entering its sixth year and has become known nationally for the clinical engagement it delivers to early-stage companies.

For HeartX, HealthTech Arkansas:

  • Leads recruitment efforts.

  • Presents finalist companies to the hospital selection committee for interviews and selections.

  • Identifies pilot champions/PIs at participating hospitals.

  • Facilitates pilot projects and clinical trials.

  • Manages the investment fund that runs in parallel to the accelerator.

 

Learn more about HealthTech Arkansas in this short video:

 

MedAxiom, the cardiovascular community’s premier source for organizational performance solutions, is transforming cardiovascular care by bridging technology, innovation and care delivery. MedAxiom unites cardiovascular organizations, leaders and industry partners to achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience, and improved clinician experience.

For HeartX, MedAxiom will offer a robust set of services to cohort companies, including:

  • A webinar to the MedAxiom membership

  • Exhibition at a MedAxiom conference

  • Representation on MedAxiom’s website

  • Access to deliver content via MedAxiom channels

  • Access to MedAxiom operational data

 

See what MedAxiom provides to HeartX cohort members:

2024 Program

APPLICATIONS OPEN FEBRUARY 1 - APRIL 30, 2024.

COHORT CHOSEN SEPTEMBER 3, 2024.

PROGRAM KICKOFF OCTOBER 16 - 19, 2024 (DENVER, CO).
Early stage HealthTech companies are encouraged to apply to our virtual program! Five companies are chosen each year to participate, and those five companies receive the following benefits:
  • Transfer what you've learned in a past accelerator into true clinical engagement.

  • Guaranteed pilot projects with at least two cardiology practices in Arkansas and participating MedAxiom member practices around the country, giving you the chance to improve your product/service/technology and demonstrate value to our providers. These pilots have the potential to convert to commercial contracts based upon the value you demonstrate.

  • $150,000 of up-front investment in the form of a SAFE agreement or convertible note on market terms.

  • Access to the HeartX Fund and our investing partners for potential follow-on investments.

  • A clinical mentor assigned to your team from each provider with whom you execute a pilot project. That mentor - in conjunction with the clinical trials manager at HealthTech Arkansas - will work exclusively on your behalf to help make your pilot project the most successful it can be.

  • No requirement to be onsite for a fixed duration during the program. You’ll visit your designated pilot sites around the country just as you would with any other pilot project. All other content and communications are conducted remotely by phone and video conference.

  • Access to the robust, statewide mentor network assembled by the HealthTech Arkansas team.
    •
Requirements for your participation:
  • Be ready to onboard patients into your pilot project or clinical trial within 12 months of entering the program. For the current year, that means your clinical engagement should begin sometime from October 2024 to October 2025.

  • Have data from other pilot projects. In other words, we can’t be your first pilot.

  • You need to have raised at least $500K in external capital.

  • Willingness to accept $150K of up-front investment in the form of a SAFE or convertible note, with a cap and discount rate negotiated with the HeartX team.

  • Willingness to issue a $50K in-kind investment position to HealthTech Arkansas in exchange for the pilot projects and clinical trials and access to the HeartX network, and a $50K in-kind investment position to MedAxiom in exchange for the suite of custom services offered by them.

  • Be able to attend the MedAxiom CV Transforum Conference in Denver, Colorado October 16-19, 2024 for the program kickoff.

2023 COHORT

PAST PARTICIPANTS

2022 Cohort

2021 COHORT

2020 COHORT

2019 COHORT

2018 COHORT

HeartX Fund Managers

The HeartX Fund is established to invest in the companies participating in the annual HeartX cohorts and offers differentiated investing opportunities for accredited investors. To learn more, please contact Jeff Stinson at jeff@healthtecharkansas.com.

"The HealthTech Arkansas team brought us a collection of companies in 2018 with disruptive technologies with the potential to increase our quality of care and make us more efficient. We enthusiastically support the program and look forward to seeing and working with the new crop of companies in 2019.”
–Drew Jackson, President, Arkansas Heart Hospital
“The increasing opportunity of leveraging technology in healthcare — especially in near real-time knowledge creation from large volumes of data — can profoundly impact health outcomes. The world-class technologies we get to see through HealthTech Arkansas have the potential to significantly improve the quality of care, and we look forward to our continued partnership.”
–Dr. Joseph Sanford, CMIO, UAMS Assistant Professor , Department of Anesthesiology
“Having a program that allows you to get fairly deep access — not just to senior decision-makers, but to actual users that will be the recipients and beneficiaries of the product — that is the type of access that most development-oriented companies lack. Having a program that bridges that gap and connects us to healthcare providers has been immensely impactful.”
–Jong Lee , Day Zero Diagnostics
“It’s been phenomenal to partner with HealthTech Arkansas because they have provided us access to those key providers and key partner hospitals who are so crucial to helping us build the right strategy for our business.”
–Jared Greer , Lapovations
“HealthTech Arkansas as an accelerator has been extremely unique. They guaranteed us access to at least two pilot locations. Providers that were genuinely interested in working with ExplORer Surgical and were excited to have us in their hospitals.”
–Brittany Genelin , ExplORer Surgical
"HealthTech Arkansas was a true accelerator for Ejenta. They connected us to great champions at the Arkansas Heart Hospital and UAMS, and Ejenta now has two deployments underway in Arkansas!"
–Rachna Dhamija, CEO , Ejenta
"Jeff and his team found clinical partners willing to work closely with health startups to validate their products both clinically and financially. This is a huge benefit to medical startups, where there are so many great ideas, yet few places to test them. We look forward to continuing to work with everyone, well past the end of the official program."
–Jeanie Smith, Strategic Account Manager & Inside Sales Manager , Medical Informatics Corp.
"HealthTech Arkansas has positioned Arkansas as one the true epicenters for innovation in healthcare. The macro-eyes experience of working with AHH, UAMS, and the HealthTech Arkansas team has been phenomenal."
–Benjamin Fels, CEO and Founder , Macro-Eyes
"Health Tech Arkansas's program has been a great experience. The team has helped us cut through the usual red tape part of the pilot process and paired us up with the right stakeholders at healthcare organizations to make things happen."
–Joshua Reischer , Health Note
"HealthTech Arkansas (HTA) combines state-of-the-art hospitals, forward-thinking clinicians, unique business opportunities, and even seed financing into a wonderful program that’s ideal for early-stage MedTech companies. Working with HTA’s leadership, my start-up quickly planned a novel, cost-efficient clinical trial with a program that would normally take months (and significant capital) elsewhere. Plus, with HTA, we get the chance to interact and collaborate with likeminded companies. This program is fantastic on multiple fronts!"
–Matt Banet , toSense
"HealthTech Arkansas has been an unbelievable resource for OMNY. Their partnerships have proven to be an incredible resource for our company's growth over the last year."
–Mitesh Rao , OMNY

CONTACT 

JEFF STINSON, PROGRAM DIRECTOR
JEFF@HEALTHTECHARKANSAS.COM

© 2024 HeartX. All Rights Reserved.

Privacy Policy